Interesting how a Pharma gets valued. ANAC Vince’s sale of $5.3 Billion USD. Went from $5 to $155 ATH. Pfizer wanted CrisaboleTM. Usually Takeovers can be either based on Price/Sales or Price/Earnings 15 times… I wouldn’t be surprised if BOT does a consolidation of shares like NEU did, to get more interest from the institutions. DYOR
Ann: FDA Letter Requires Patient Instruction Update, page-137
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.005(1.19%) |
Mkt cap ! $760.2M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 41.3¢ | $639.8K | 1.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 547008 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 866387 | 8 |
View Market Depth
| Last trade - 10.38am 05/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |